Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The normal hematocrit study--follow-up.
Besarab A, Goodkin DA, Nissenson AR; Normal Hematocrit Cardiac Trial Authors. Besarab A, et al. Among authors: goodkin da. N Engl J Med. 2008 Jan 24;358(4):433-4. doi: 10.1056/NEJMc076523. N Engl J Med. 2008. PMID: 18216370 No abstract available.
The Normal Haematocrit Trial in dialysis patients with cardiac disease.
Besarab A, Bolton WK, Nissenson AR, Schwab SJ, Goodkin DA. Besarab A, et al. Among authors: goodkin da. Nephrol Dial Transplant. 1999 Aug;14(8):2043-4. doi: 10.1093/ndt/14.8.2043-a. Nephrol Dial Transplant. 1999. PMID: 10462300 No abstract available.
Target haematocrit during erythropoietin therapy.
Nissenson AR, Besarab A, Bolton WK, Goodkin DA, Schwab SJ. Nissenson AR, et al. Among authors: goodkin da. Nephrol Dial Transplant. 1997 Sep;12(9):1813-6. doi: 10.1093/ndt/12.9.1813. Nephrol Dial Transplant. 1997. PMID: 9306325 Review. No abstract available.
The normal hematocrit cardiac trial revisited.
Goodkin DA. Goodkin DA. Semin Dial. 2009 Sep-Oct;22(5):495-502. doi: 10.1111/j.1525-139X.2009.00620.x. Epub 2009 Jul 24. Semin Dial. 2009. PMID: 19650856
The end stage renal disease program.
Goodkin DA. Goodkin DA. N Engl J Med. 1993 Jul 8;329(2):140; author reply 140-1. N Engl J Med. 1993. PMID: 8510703 No abstract available.
Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients.
Paganini EP, Eschbach JW, Lazarus JM, Van Stone JC, Gimenez LF, Graber SE, Egrie JC, Okamoto DM, Goodkin DA. Paganini EP, et al. Among authors: goodkin da. Am J Kidney Dis. 1995 Aug;26(2):331-40. doi: 10.1016/0272-6386(95)90654-1. Am J Kidney Dis. 1995. PMID: 7645538 Free article. Clinical Trial.
70 results